BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22293895)

  • 1. Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders.
    Hashizume H; Uchiyama I; Kawamura T; Suda T; Takigawa M; Tokura Y
    Acta Derm Venereol; 2012 May; 92(3):276-7. PubMed ID: 22293895
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
    Sadasivam N; Johnson RJ; Owen RG
    Br J Haematol; 2014 Jun; 165(5):584. PubMed ID: 24456137
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
    Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
    Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis.
    Attard AA; Praveen P; Dunn PJ; James GJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):e37-9. PubMed ID: 22769419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous remission of methotrexate-associated lymphoproliferative disorder with Epstein-Barr virus type II latency.
    Matsuzaki Y; Minakawa S; Sagara C; Takiyoshi N; Nakano H; Sawamura D
    Eur J Dermatol; 2018 Oct; 28(5):693-694. PubMed ID: 30325313
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.
    Ravi PY; Sigamani E; Jeelani Y; Manipadam MT
    Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
    Curry JL; Prieto VG; Jones DM; Vega F; Duvic M; Diwan AH
    J Cutan Pathol; 2011 Mar; 38(3):295-7. PubMed ID: 19889052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases.
    Fujimoto M; Takai T; Okada M; Okuno A; Haga H
    Am J Dermatopathol; 2021 Aug; 43(8):604-605. PubMed ID: 33606374
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.
    Sato N; Toide N; Kizawa M; Ohkubo T; Ishibashi S; Sanjo N; Yokota T
    J Neurol Sci; 2017 Aug; 379():219-221. PubMed ID: 28716244
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
    Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
    J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
    Starkebaum G
    J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral ulceration associated with concurrent herpes simplex virus, cytomegalovirus, and Epstein-Barr virus infection in an immunocompromised patient.
    Mainville GN; Marsh WL; Allen CM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):e306-14. PubMed ID: 25544404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias.
    Ramia de Cap M; Michaels PD
    Mod Pathol; 2021 Nov; 34(11):2084. PubMed ID: 33758325
    [No Abstract]   [Full Text] [Related]  

  • 15. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
    Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
    [No Abstract]   [Full Text] [Related]  

  • 16. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
    Bruce AJ; Subtil A; Rogers RS; Castro LA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
    Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
    J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.
    Dojcinov SD; Venkataraman G; Raffeld M; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2010 Mar; 34(3):405-17. PubMed ID: 20154586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
    García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R
    Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.